Constantine Dean Katsamakis, DO Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Health Center Dr, Mattoon, IL 61938 Phone: 217-238-4960 Fax: 217-238-4951 |
News Archive
The National Psoriasis Foundation, NPF, has awarded $2.3 million in research grants and fellowships in 2018. This year's awards bring the total amount NPF has invested in the advancement of psoriatic disease research to more than $19 million.
Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.
Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, information that could help lead to earlier detection and new treatments.
A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons shows that a drug given to some pregnant women to prevent severe respiratory ailments in preterm newborns reduces healthcare costs.
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
› Verified 4 days ago